A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
Clinical trial NCT04626635 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04626635
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2026-11-13
- Enrollment
- 548
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.